国邦医药：截至11月底累计回购1.34亿元股份用于激励

Core Viewpoint - The company announced a share repurchase plan aimed at enhancing employee stock ownership and equity incentives, with a total repurchase amount expected between 100 million to 200 million yuan [1] Group 1: Share Repurchase Plan - The share repurchase period is set from March 11, 2025, to March 10, 2026 [1] - As of November 30, 2025, the company has repurchased a total of 6.7515 million shares, representing 1.21% of the total share capital [1] - The highest transaction price recorded was 23.74 yuan per share, while the lowest was 18.61 yuan per share, with a total expenditure of 134 million yuan [1]